Using Telehealth to Improve Buprenorphine Access During and After COVID-19: A Rapid Response Initiative in Rhode Island
Despite its proven efficacy, buprenorphine remains dramatically underutilized for management of opioid use disorder largely due to onerous barriers to treatment initiation. During the COVID-19 pandemic, many substance use disorder treatment facilities have reduced their hours and services, exacerbating existing barriers. To this end, the U.S. Drug Enforcement Administration and Substance Abuse Mental Health Services Administration adjusted their guidelines to allow for new buprenorphine prescriptions following audio-only telehealth encounters, no longer requiring an in-person evaluation prior to treatment initiation. (Sour...
Source: Journal of Substance Abuse Treatment - January 19, 2021 Category: Addiction Authors: Seth A. Clark, Elizabeth A. Samuels, Rachel S. Wightman, Caroline Wunsch, Lee Ann Jordison Keeler, Neha Reddy, Corey Davis Source Type: research

Association Between Methadone or Buprenorphine Use During Medically Supervised Opioid Withdrawal and Extended-Release Injectable Naltrexone Induction Failure
Extended-release naltrexone (XR-NTX) is an effective maintenance treatment for opioid use disorder, but induction from active opioid use is a challenge as individuals must complete detoxification before induction. We aimed to determine whether use of methadone or buprenorphine, long acting agonist opioids commonly used for detoxification, were associated with decreased likelihood of induction onto XR-NTX. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 15, 2021 Category: Addiction Authors: Matisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, Martina Pavlicova, Jonathan Wai, Patrick Haenlein, Babak Tofighi, Aimee N.C. Campbell, Joshua D. Lee, John Rotrosen, Edward V. Nunes Source Type: research

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
Federal regulatory changes during the COVID-19 pandemic allow buprenorphine to be prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers limited broad uptake of buprenorphine among people who use drugs at the system, provider, and patient levels, including lack of available DATA 2000 waivered clinicians to prescribe, stigma, and competing livelihood priorities. As two harm reduction primary care programs in New York State that care for people who use drugs and offer buprenorphine, one rural (Ithaca) and one urban (Manhattan), we have rapidly adopted telemedicine to initiate buprenorphine t...
Source: Journal of Substance Abuse Treatment - January 15, 2021 Category: Addiction Authors: Linda Wang, Jeffrey Weiss, Elizabeth Bogel Ryan, Justine Waldman, Stacey Rubin, Judy L. Griffin Source Type: research

Justice Community Opioid Innovation Network (JCOIN): The TCU research hub
Recognizing the current opioid crisis among justice-involved individuals and the need to intervene at the intersection of justice and community health, the JCOIN TCU hub study explores outcomes associated with a multi-level hybrid implementation approach. The study capitalizes on facilitated collaboration, training, and cross-system data sharing to leverage improvements in criminal justice (CJ) and community behavioral health (CBH) interagency collaboration. The goal is to improve local community public health and safety outcomes for reentering justice-involved individuals who have a history of (or are at risk for) using o...
Source: Journal of Substance Abuse Treatment - January 14, 2021 Category: Addiction Authors: Danica Knight, Jennifer Becan, David Olson, Noah Painter Davis, Justin Jones, Amanda Wiese, Pam Carey, Dona Howell, Kevin Knight Source Type: research

Long-term functioning to provide empirical support for the clinical relevance of treatment outcomes for methamphetamine use disorders
This study evaluated the association between different MA use outcomes and long-term life-functioning. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 14, 2021 Category: Addiction Authors: Andr é Q.C. Miguel, Crystal L. Smith, Ekaterina Burduli, John M. Roll, Sterling McPherson Source Type: research

Recovery community centers: Characteristics of new attendees and longitudinal investigation of the predictors and effects of participation
Recovery community centers (RCCs) have expanded across the U.S., serving as social “recovery hubs” that increase recovery capital (e.g., employment, housing) by providing resources that clinical care does not provide. While research supports RCCs' general utility, little is known about new participants' characteristics, predictors of engagement, services used, and benefits der ived. Greater knowledge would inform the field about RCCs' clinical and public health potential. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 12, 2021 Category: Addiction Authors: John F. Kelly, Nilofar Fallah-Sohy, Julie Cristello, Robert L. Stout, Leonard A. Jason, Bettina B. Hoeppner Source Type: research

Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study
During the COVID-19 pandemic, opioid treatment programs (OTPs) in the U.S. were granted new flexibility in methadone dispensing and the use of telemedicine. To explore the impact of the pandemic and accompanying policy changes on service delivery, we asked OTP clinicians about changes in care patterns and perceptions of impacts on access and quality. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 12, 2021 Category: Addiction Authors: Sarah B. Hunter, Alex R. Dopp, Allison J. Ober, Lori Uscher-Pines Source Type: research

A systematic review of integrative medicine for opioid withdrawal
The United States has been battling an opioid epidemic for decades. As substance use disorders have grown, so too has investigation into treatment options, including integrative medicine approaches, for managing opioid withdrawal symptoms (OWS). (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 10, 2021 Category: Addiction Authors: Caroline Kruszecki, Courtney R. Cameron, Anne L. Hume, Kristina E. Ward Source Type: research

Kentucky Women's Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women
The opioid crisis has disproportionately affected women, but research on approaches to increase initiation of medications for opioid use disorder (MOUD) among women is limited. The Kentucky Justice Community Opioid Innovation Network (JCOIN) will implement a type 1 hybrid effectiveness and implementation trial to examine an innovative MOUD pretreatment model using telehealth (alone and in combination with peer navigators) for justice-involved women in transition from jail to the community. The overall goal of the project is to increase initiation and maintenance of MOUD among high-risk justice-involved women during communi...
Source: Journal of Substance Abuse Treatment - January 8, 2021 Category: Addiction Authors: Michele Staton, J. Matthew Webster, Carl Leukefeld, Martha Tillson, Katherine Marks, Carrie Oser, Heather M. Bush, Laura Fanucchi, Amanda Fallin-Bennett, Bryan R. Garner, Kathryn McCollister, Sarah Johnson, Erin Winston Source Type: research

Impact of benzodiazepines and polysubstance status on repeat non-fatal drug overdoses
This study analyzed TN hospital discharge data on nonfatal overdoses for patients ages 18 –64 from 2012 to 2016 for 21,066 patients with an initial inpatient visit and 36,244 patients with an initial outpatient visit. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 8, 2021 Category: Addiction Authors: Sarah Mayberry, Sarah Nechuta, Shanthi Krishnaswami Source Type: research

Sexual-risk reduction following the referral of syringe exchange registrants to methadone maintenance: Impact of gender and drug use
This study evaluates the impact of enrolling syringe exchange registrants in methadone maintenance on change in sexual-risk behaviors. Baltimore Needle Exchange Program (BNEP) registrants (n  = 210) participated in a parent study evaluating strategies for initiating methadone maintenance treatment and the study followed them for six months. Study staff administered the Risk Assessment Battery (RAB; Metzger, 1993) monthly throughout treatment. Staff conducted urinalysis testing weekl y. Results showed that treatment enrollment reduced sexual-risk behaviors at month 1, though a longer treatment duration provided no furth...
Source: Journal of Substance Abuse Treatment - January 8, 2021 Category: Addiction Authors: Michael Kidorf, Robert K. Brooner, Haijuan Yan, Jessica Peirce Source Type: research

Kentucky Women ’s Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women
The opioid crisis has disproportionately affected women, but research on approaches to increase initiation of medications for opioid use disorder (MOUD) among women is limited. The Kentucky Justice Community Opioid Innovation Network (JCOIN) will implement a type 1 hybrid effectiveness and implementation trial to examine an innovative MOUD pretreatment model using telehealth (alone and in combination with peer navigators) for justice-involved women in transition from jail to the community. The overall goal of the project is to increase initiation and maintenance of MOUD among high-risk justice-involved women during communi...
Source: Journal of Substance Abuse Treatment - January 8, 2021 Category: Addiction Authors: Michele Staton, J. Matthew Webster, Carl Leukefeld, Martha Tillson, Katherine Marks, Carrie Oser, Heather M. Bush, Laura Fanucchi, Amanda Fallin-Bennett, Bryan R. Garner, Kathryn McCollister, Sarah Johnson, Erin Winston Source Type: research

Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)
A major driver of the U.S. opioid crisis is limited access to effective medications for opioid use disorder (MOUD) that reduce overdose risks. Traditionally, jails and prisons in the U.S. have not initiated or maintained MOUD for incarcerated individuals with OUD prior to their return to the community, which places them at high risk for fatal overdose. A 2018 law (Chapter 208) made Massachusetts (MA) the first state to mandate that five county jails deliver all FDA-approved MOUDs (naltrexone [NTX], buprenorphine [BUP], and methadone). (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 7, 2021 Category: Addiction Authors: Elizabeth A. Evans, Thomas J. Stopka, Ekaterina Pivovarova, Sean M. Murphy, Faye S. Taxman, Warren J. Ferguson, Dana Bernson, Claudia Santelices, Kathryn E. McCollister, Randall Hoskinson, Thomas Lincoln, Peter D. Friedmann, MassJCOIN Research Group Source Type: research

Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19
Methadone maintenance treatment is a life-saving treatment for people with opioid use disorders (OUD). The coronavirus pandemic (COVID-19) has introduced many concerns surrounding access to opioid treatment. In March 2020, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued guidance allowing for the expansion of take-home methadone doses. We sought to describe changes to treatment experiences from the perspective of persons receiving methadone at outpatient treatment facilities for OUD. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 7, 2021 Category: Addiction Authors: Mary C. Figgatt, Zach Salazar, Elizabeth Day, Louise Vincent, Nabarun Dasgupta Source Type: research

Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for treatment to opioid use disorder treatment for court-involved adults
In response to the opioid crisis in New York State (NYS), the Unified Court System developed a new treatment court model —the opioid intervention court—designed around 10 Essential Elements of practice to address the flaws of existing drug courts in handling those with opioid addiction via broader inclusion criteria, rapid screening, and linkage to medications to treat opioid use disorder (MOUD). The new court is now being rolled out statewide yet, given the innovation of the opioid court, the exact barriers to implementation in different counties with a range of resources are largely unknown. (Source: Journal ...
Source: Journal of Substance Abuse Treatment - January 7, 2021 Category: Addiction Authors: Katherine S. Elkington, Edward Nunes, Annie Schachar, Margaret Ryan, Alejandra Garcia, Kelly Van DeVelde, Dennis Reilly, Megan O ’Grady, Arthur R. Williams, Susan Tross, Patrick Wilson, Renee Cohall, Alwyn Cohall, Milton Wainberg Source Type: research

A Collision of Crises: Addressing an HIV Outbreak among People who Inject Drugs in the midst of COVID-19
(Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 6, 2021 Category: Addiction Authors: Jessica L. Taylor, Glorimar Ruiz-Mercado, Heather Sperring, Angela R. Bazzi Source Type: research

Adaptations to substance use disorder monitoring by physician health programs in response to COVID-19
(Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 6, 2021 Category: Addiction Authors: Alexis Polles, Christopher Bundy, William Jacobs, Lisa J. Merlo Source Type: research

Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries
Opioid use disorder in the United States ’ Medicare population increased from 10 to 24 per 1,000 from 2012 to 2018. Understanding the changes in the patterns of opioid overdose mortality over time holds broad clinical and public health relevance. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 6, 2021 Category: Addiction Authors: Yong-Fang Kuo, Jacques Baillargeon, Mukaila A. Raji Source Type: research

Substance use predictors of attendance among veterans in integrated PTSD and alcohol use disorder treatment
This study examined substance use –related predictors of session attendance among veterans (N = 119) randomized to receive integrated exposure therapy (Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure [COPE]; Back et al., 2015) or integrated coping skills therapy (Seeking Safety [SS]; Najavits, 200 2) in a clinical trial for comorbid PTSD+AUD (Norman et al., 2019). (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 6, 2021 Category: Addiction Authors: Alexander C. Kline, Elizabeth Straus, Robert C. Lyons, Abigail C. Angkaw, Brittany C. Davis, Moira Haller, Denise Hien, Sonya B. Norman Source Type: research

Increased HIV testing in people who use drugs hospitalized in the first wave of the COVID-19 pandemic
People who use drugs (PWUD) often experience barriers to preventative health care. During the COVID-19 pandemic, due to lapses in harm reduction services, several public health experts forecasted subsequent increases in diagnosis of HIV in PWUD. As many inpatient hospitals reworked patient flow during the COVID-19 surge, we hypothesized that HIV testing in PWUD would decrease. To answer this question, we compiled a deidentified list of hospitalized patients with electronic medical record indicators of substance use —a positive urine toxicology screen, prescribed medications to treat opioid use disorder, a positive CI...
Source: Journal of Substance Abuse Treatment - January 5, 2021 Category: Addiction Authors: Julia Zubiago, Meghan Murphy, Rubeen Guardado, Denise Daudelin, Dustin Patil, Alysse Wurcel Source Type: research

Increased availability of telehealth mental health and substance abuse treatment for peripartum and postpartum women: A unique opportunity to increase telehealth treatment
Since the onset of the COVID-19 pandemic, several federal, state, and payor policy changes have facilitated the uptake of telehealth service delivery. These changes have resulted in a significant uptick in the utilization of maternal mental health and substance use disorder screening and treatment services for pregnant and postpartum women. The Medical University of South Carolina ’s [MUSC] Women’s Reproductive Behavioral Health Program provides outpatient mental health and substance use treatment to pregnant and postpartum women within obstetric practices. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 4, 2021 Category: Addiction Authors: Angela Moreland, Constance Guille, Jenna L. McCauley Source Type: research

Integrated substance use and prenatal care delivery in the era of COVID-19
The COVID-19 pandemic has directly impacted integrated substance use and prenatal care delivery in the United States and has driven a rapid transformation from in-person prenatal care to a hybrid telemedicine care model. Additionally, changes in regulations for take home dosing for methadone treatment for opioid use disorder due to COVID-19 have impacted pregnant and postpartum women. We review the literature on prenatal care models and discuss our experience with integrated substance use and prenatal care delivery during COVID-19 at New England ’s largest safety net hospital and national leader in substance use care...
Source: Journal of Substance Abuse Treatment - January 1, 2021 Category: Addiction Authors: Elizabeth W. Patton, Kelley Saia, Michael D. Stein Source Type: research

A randomized comparison of 4 vs. 16 weeks of psychosocial treatment for stimulant users
Controlled studies provide little empirical evidence to inform clinical recommendations for the optimal duration (i.e., “dosage”) of psychosocial treatment for substance use disorders (SUDs). The current study prospectively examined the relationships among treatment dosage, participant adherence to the treatment regimen, and treatment outcomes in a population of adults with stimulant use disorder (cocaine and/or methamphetamine). The study randomly assigned eighty-five participants to receive either 4 weeks or 16 weeks of standardized outpatient treatment. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - January 1, 2021 Category: Addiction Authors: Richard Rawson, Suzette Glasner Edwards, Mary-Lynn Brecht, David Farabee Source Type: research

Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration
Buprenorphine treatment remains unavailable in many jails and prisons, but use of nonprescribed (i.e., diverted) buprenorphine has been reported in these settings. The purpose of this analysis is to explore the experiences and motivations behind the use of diverted buprenorphine among recently incarcerated individuals. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 28, 2020 Category: Addiction Authors: Laura Monico, Jan Gryczynski, Joshua D. Lee, Kristi Dusek, Ryan McDonald, Mia Malone, Anjalee Sharma, Anna Cheng, Angela DeVeaugh-Geiss, Howard Chilcoat Source Type: research

Reaching nontreatment-seeking cannabis users: Testing an extended marijuana check-up intervention
Some adult cannabis users report negative consequences of use but do not seek treatment. Nonjudgmental, brief interventions incorporating motivational interviewing techniques may be able to reach users who otherwise would not seek treatment and increase their motivation to change use. Previous studies have shown brief interventions with this population are efficacious in reducing use, but the absolute amount of change has not clearly translated into meaningful reductions in associated negative consequences. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 28, 2020 Category: Addiction Authors: Robert S. Stephens, Robrina Walker, Stephanie A. Fearer, Roger A. Roffman Source Type: research

Substance use treatment in Appalachian Tennessee amid COVID-19: Challenges and preparing for the future
The COVID-19 pandemic created a number of rapidly emerging and unprecedented challenges for those engaged in substance use disorder (SUD) treatment, forcing service providers to improvise their treatment strategies as the crisis deepened. Drawing from five ongoing federally funded SUD projects in Appalachian Tennessee and hundreds of hours of meetings and interviews, this article explores the pandemic ’s impacts on an already structurally disadvantaged region, its recovery community, and those who serve them. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 28, 2020 Category: Addiction Authors: Satish K. Kedia, Michael Schmidt, Patrick J. Dillon, Hassan Arshad, Xinhua Yu Source Type: research

Caring for hospitalized patients during dual public health emergencies
(Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 28, 2020 Category: Addiction Authors: Andrea Ryan, Emma Garrod, Nadia Fairbairn Source Type: research

Sharp Decline in Hospital and Emergency Department Initiated Buprenorphine for Opioid Use Disorder During COVID-19 State of Emergency in California
The California Bridge Program supports expansion of medications for opioid use disorder (MOUD) in emergency departments (EDs) and hospital inpatient units across the state. Here, we describe the change in activity before and after the coronavirus disease 2019 (COVID-19) California statewide shutdown. Of the 70 participating hospitals regionally distributed across California, 52 report MOUD-related activity monthly. We analyzed data on outcomes of OUD care and treatment: identification of OUD, acceptance of referral, receipt of buprenorphine prescription, administration of buprenorphine, and follow-up linkage to outpatient ...
Source: Journal of Substance Abuse Treatment - December 26, 2020 Category: Addiction Authors: Andrew A. Herring, Mariah Kalmin, Melissa Speener, David Goodman-Meza, Hannah Snyder, Arianna Sampson, Aimee Moulin, Steve Shoptaw Source Type: research

Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder
The U.S. government declared the opioid epidemic as a national public health emergency in 2017, but regulatory frameworks that govern the treatment of opioid use disorder (OUD) through pharmaceutical interventions have remained inflexible. The emergence of the COVID-19 pandemic has effectively removed regulatory restrictions that experts in the field of medications for opioid use disorder (MOUD) have been proposing for decades and has expanded access to care. The regulatory flexibilities implemented to avoid unnecessary COVID-related death must be made permanent to ensure that improved access to evidence-based treatment re...
Source: Journal of Substance Abuse Treatment - December 26, 2020 Category: Addiction Authors: Kristi Lynn Stringer, Kirsten J. Langdon, Michelle McKenzie, Brad Brockmann, Phillip Marotta Source Type: research

An efficacy trial of adaptive interventions for alcohol use disorder
This study used a sequential multiple assignment randomized trial design with 160 individuals with AUD recruited both locally and nationally who had a goal to reduce or abstain from drinking. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 26, 2020 Category: Addiction Authors: Jon Morgenstern, Alexis Kuerbis, Sijing Shao, Hayley Treloar Padovano, Svetlana Levak, Nehal P. Vadhan, Kevin G. Lynch Source Type: research

Diagnosis and treatment of substance use disorder among pregnant women in three state Medicaid programs from 2013 to 2016
Substance use disorder (SUD) during pregnancy increases risks of adverse outcomes for mothers and children. Because Medicaid covers about half of all births and maternal SUD is a costly problem, describing the timing of enrollment and health care that Medicaid-enrolled pregnant women with SUDs receive is critical to understanding gaps in the timeliness and specificity of SUD diagnosis and treatment for pregnant women with SUDs. We used linked maternal and infant Medicaid claims and enrollment data and infant birth records from three states (n=72,086 mother-infant dyads) to estimate the share of sample women diagnosed with ...
Source: Journal of Substance Abuse Treatment - December 26, 2020 Category: Addiction Authors: Victoria Lynch, Lisa Clemans-Cope, Embry Howell, Ian Hill Source Type: research

C2: editorial board
(Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 22, 2020 Category: Addiction Source Type: research

TOC (update)
(Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 22, 2020 Category: Addiction Source Type: research

Examining correlates of cannabis users ’ engagement with a digital intervention for substance use disorder: An observational study of clients in UK services delivering Breaking Free Online
This study aimed to understand how participants ’ baseline sociodemographic and clinical characteristics are associated with engagement with BFO, and how both participants’ characteristics and their engagement may be associated with cannabis use and biopsychosocial functioning at follow-up. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 20, 2020 Category: Addiction Authors: Sarah Elison-Davies, Jeffrey D. Wardell, Lena C. Quilty, Jonathan Ward, Glyn Davies Source Type: research

Health economic analyses of the Justice Community Opioid Innovation Network (JCOIN)
The Justice Community Opioid Innovation Network (JCOIN) will generate real-world evidence to address the unique needs of people with opioid use disorder (OUD) in justice settings. Evidence regarding the economic value of OUD interventions in justice populations is limited. Moreover, the variation in economic study designs is a barrier to defining specific interventions as broadly cost-effective. The JCOIN Health Economics Analytic Team (HEAT) has worked closely with the Measures Committee to incorporate common economic measures and instruments across JCOIN studies, which will: a) ensure rigorous economic evaluations within...
Source: Journal of Substance Abuse Treatment - December 20, 2020 Category: Addiction Authors: Sean M. Murphy, Neda Laiteerapong, Mai T. Pho, Danielle Ryan, Iv án Montoya, Theresa I. Shireman, Elbert Huang, Kathryn E. McCollister Source Type: research

Considering the harms of our habits: the reflexive urine drug screen in opioid use disorder treatment
The COVID-19 pandemic has led to abrupt changes in the delivery of substance use treatment, notably the adoption of telehealth services and a departure from mandatory urine drug screens (UDS). Amid current circumstances, the UDS, which had evolved to signal a “successful” recovery, no longer seems feasible, safe, or necessary. Even prior to the pandemic, the UDS had notable drawbacks, including sending a message of mistrust and hierarchy, potentially causing psychological trauma, and incentivizing falsification. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 19, 2020 Category: Addiction Authors: Utsha Khatri, Shoshana V. Aronowitz Source Type: research

Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes
Improving access to medications for opioid use disorder (MOUD) is a national priority; however, these efforts commonly focus on the provider. Access to buprenorphine through retail pharmacies and stigma associated with filling prescriptions for MOUD pose additional barriers for patients when embarking on their road to recovery. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 17, 2020 Category: Addiction Authors: Asif Khan, Qudsia Khan, Elizabeth Kolb Source Type: research

Rates and predictors of brief intervention for women veterans returning from recent wars: Examining gaps in service delivery for unhealthy alcohol use
This study aimed to examine gaps in implementation of BI practice for women veterans through identifying rates of BI at different alcohol risk levels (AUDIT-C=3 –4; =5–7; =8–12), and the role of alcohol risk level and other factors in predicting receipt of BI. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 17, 2020 Category: Addiction Authors: Marianne Pugatch, Grace Chang, Deborah Garnick, Mary Brolin, Deborah Brief, Christopher Miller, Jerry Fleming, Daryl Blaney, Brian Harward, Dominic Hodgkin Source Type: research

Episodic Future Thinking for smoking cessation in individuals with substance use disorder: Treatment feasibility and acceptability
Smokers with substance use disorders (SUD) smoke approximately four times more than the general population. Current efforts are focused on improving smoking cessation treatments for this population. Episodic future thinking (EFT), a novel intervention aimed at decreasing impulsive choice, has shown promising results for reducing cigarette demand in experimental settings. This feasibility study sought to examine the feasibility and preliminary EFT effects on delay discounting (DD) and nicotine intake reductions throughout treatment (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 17, 2020 Category: Addiction Authors: Gema Aonso-Diego, Alba Gonz ález-Roz, Víctor Martínez-Loredo, Andrea Krotter, Roberto Secades-Villa Source Type: research

Impacts of COVID-19 on residential treatment programs for substance use disorder
The COVID-19 pandemic may present special challenges for residential substance use disorder (SUD) treatment facilities, which may lack infrastructure and support to implement infection control protocols while maintaining on-site treatment services. However, how residential SUD treatment programs are impacted by the COVID-19 pandemic is little known. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 16, 2020 Category: Addiction Authors: A. Pagano, S. Hosakote, K. Kapiteni, E. Straus, J. Wong, J. Guydish Source Type: research

Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts
Veterans have high rates of cannabis use, and rates of cannabis use disorder (CUD) are rising among this population. These rising rates are particularly true for veterans with post-traumatic stress disorder (PTSD), which is common among veterans of recent conflicts, Operations Enduring Freedom, Iraqi Freedom, and Operation New Dawn (OEF/OIF/OND). Although prior work has documented links between PTSD and cannabis use, a better understanding of the intersection among CUD, PTSD, and other disorders in real-world clinical practice can inform prevention and treatment efforts. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 15, 2020 Category: Addiction Authors: Jennifer L. Bryan, Julianna Hogan, Jan A. Lindsay, Anthony Ecker Source Type: research

A chance to do it better: Methadone maintenance treatment in the age of Covid-19
Methadone maintenance treatment (MMT) in the United States, and particularly the clinic system of distribution, is often criticized as punitive, over-regulated, and misaligned to the needs of many patients. However, changes to the regulations that COVID-19 caused may have provided an opportunity for improving service. This commentary uses literature and my own experience to provide a brief description of how MMT programs responded to the threat of Covid-19 and how such responses fit into the larger context of attempts to reform treatment. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 11, 2020 Category: Addiction Authors: David Frank Source Type: research

Addressing a rapidly changing service landscape during the COVID-19 pandemic: Creation of the Oregon substance use disorder resource collaborative
Following the rising crisis of COVID-19 and the Oregon governor ’s stay-at-home orders, members of the Oregon Health and Science University (OHSU) inpatient addiction consult service recognized that local addiction treatment and recovery organizations were operating at limited capacity. As a result, discharge planning, patient access to local community-based t reatment, and safety-net programming were affected. Given structural and intersectional risk vulnerabilities of people with substance use disorders (SUDs), the OHSU members felt that COVID-19 would disproportionately impact chronically marginalized members of o...
Source: Journal of Substance Abuse Treatment - December 10, 2020 Category: Addiction Authors: Rachel A. Lockard, Kelsey C. Priest, Patrick C.M. Brown, Amanda Graveson, Honora Englander Source Type: research

A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail
This study is a randomized, open label, controlled trial of extended-release buprenorphine (XR-B; BRIXADI ™ formulation) versus extended-release naltrexone (XR-NTX) in Maryland jails. A 7-site, open-label, equivalence design will randomly assign 240 adults with a history of opioid use disorder (OUD), stratified by gender and jail, who are nearing release to one of two treatment arms: 1) XR-B in jail o r 2) XR-NTX in jail, both followed by 6 monthly injections postrelease at a community treatment program. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 10, 2020 Category: Addiction Authors: Michael S. Gordon, Shannon Gwin Mitchell, Thomas R. Blue, Frank J. Vocci, Marc J. Fishman, Sean M. Murphy, Kathy Couvillion, Kelly Maher, Danielle Ryan, Kevin Wenzel, Martha L. Danner, Daniel K. Jarvis Source Type: research

Public implementation of a web-based program for veterans with risky alcohol use and PTSD: An RE-AIM evaluation of VetChange
Evidence-based web and mobile interventions are available for a range of mental health concerns. Little is known about how self-administered web interventions are used outside of controlled research trials, and there is a critical need to empirically examine real-world public implementation of such programs. To this end, the aim of the current study was to evaluate and describe outcomes of a nationwide public implementation of VetChange, a self-administered web intervention for veterans with problematic alcohol use and symptoms of PTSD. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 10, 2020 Category: Addiction Authors: Justin L. Enggasser, Nicholas A. Livingston, Victoria Ameral, Deborah J. Brief, Amy Rubin, Eric Helmuth, Monica Roy, Marika Solhan, Scott Litwack, David Rosenbloom, Terence M. Keane Source Type: research

COVID-19 surveillance and Black American substance use disorder: An examination of data and policy
Research has cited structural racism as a determinate of black Americans ’ susceptibility to COVID-19. Using the flu surveillance system as a template, the U.S. has collected surveillance data on COVID-19. The U.S. also has rich databases on drug use and treatment. The U.S. should use data, combined with epidemiologic modeling that includes accurate proxies for structu ral racism, to direct policy, treatment, and COVID-19 vaccine distribution priorities. This paper provides a baseline of where we are and suggestions to consider to achieve health parity in populations of color. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 10, 2020 Category: Addiction Authors: Vanessa Miller Source Type: research

Improving retention across the OUD service cascade upon reentry from jail using Recovery Management Checkups-Adaptive (RMC-A) experiment
Incarcerated individuals with opioid use disorders (OUD) should be linked to community-based treatment with medications for opioid use disorder (MOUD) upon their release, as well as to services that provide support for their ongoing recovery. The RMC-A experiment will test an adapted version of the evidence-based Recovery Management Checkups (RMC), which provides treatment linkage, support for retention, and re-linkage as indicated at quarterly checkups. A total of 750 male and female individuals will be recruited from 5 county jails in Illinois and randomly assigned to 1 of 3 groups at release from jail: a) Monitoring and...
Source: Journal of Substance Abuse Treatment - December 10, 2020 Category: Addiction Authors: Christy K. Scott, Michael L. Dennis, Christine E. Grella, Dennis P. Watson Source Type: research

Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida
This study examines factors impacting attitudes and perspectives related to MOUD that influence its utilization and acceptance in a state where support for harm reduction and treatment policy has been limited. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 10, 2020 Category: Addiction Authors: Amanda Sharp, Melissa Carlson, Veronica Howell, Kathleen Moore, Zev Schuman-Olivier Source Type: research

Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use
This study aimed to evaluate the integration of peer recovery coaches in general medical settings. Staff hired and trained nine recovery coaches as a part of a health system –wide effort to redesign SUD care. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 10, 2020 Category: Addiction Authors: Jessica F. Magidson, Susan Regan, Elizabeth Powell, Helen E. Jack, Grace E. Herman, Christopher Zaro, Martha T. Kane, Sarah E. Wakeman Source Type: research

C2: editorial board
(Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 7, 2020 Category: Addiction Source Type: research